We want to extend a very warm welcome to the three newest members of Science Club for Girls’ Board of Directors: Stephanie Aronzon, Donna Moats, and Ruby Opara Collings. We are thrilled to have these amazing women join us–– particularly at this exciting time in SCFG’s history––as we undertake significant expansion to meet the incredible demand for our programs. Together these new Board members bring a wealth of experience to SCFG, as well as a great deal of passion for our mission.
Ruby Opara Collings is Vice President, Global Internal Audit (CAE) at Haemonetics, responsible for the strategic vision and transformation of the function; she also leads Enterprise Risk Management for the company. Prior to HAE, she held multiple global positions in the 12+ years at Covidien (Medtronic), with extensive experience in audit, accounting, and controls. Ruby is a Diversity, Equity & Inclusion Ambassador, and fuels her passion via positive influence, advocacy, effective leadership, and dynamic engagement. She has been involved in numerous women’s leadership initiatives and global inclusion networks, and is currently an Advisory Board member for the Women’s Network of Greater Boston Chamber of Commerce. Ruby is a Certified Public Accountant (CPA), a Chartered Global Management Accountant (CGMA), and holds an MBA from University of Louisiana, Lafayette as well as a BSc. in Accounting from the University of Nigeria.
Donna Moats is a global marketing leader with more than 20 years in the medical device industry. She is currently Director of Global Marketing at Haemonetics where she leads a global marketing team focused on driving growth of a novel technology platform. Over the course of her career, Donna has held positions of increasing responsibility across marketing and product management as well as in research and development. She has experience creating market entry strategies for expansion into complementary market segments, managing a portfolio lifecycle, and building sustainable relationships with KOLs to support assessment of adjacent markets. Prior to joining Haemonetics in 2019, Donna held global marketing leadership roles at PAREXEL, Smith & Nephew and Covidien (now Medtronic). Throughout her career she has committed to mentoring colleagues both inside and outside of these organizations. She’s an active volunteer for the Healthcare Businesswomen’s Association and currently serving as HBA New England Regional Chair. Donna earned an MBA in Marketing from Lake Forest Graduate School of Management and holds a BS in Chemical Engineering from the University of Michigan.
Stephanie Aronzon is an Assistant General Counsel in Litigation at Fresenius Medical Care North America, the world’s largest fully integrated renal healthcare company, and serves on the Legal Department’s Diversity, Equity & Inclusion and Pro Bono Committees. Before FMCNA, she was a Senior Associate with the law firm Goodwin Procter LLP, representing clients from the technology, software, pharmaceutical, and financial industries in litigations and government investigations. Throughout her career, Stephanie has engaged with the community through her volunteer and pro bono work. Stephanie received her J.D. from New York University School of Law, a Master of Laws in Intellectual Property & Information Law from King’s College London, and a B.S. in Biology from Boston College.
Please join us in welcoming and congratulating our newest Board Members: Ruby, Donna and Stephanie! We look forward to all the great things we will accomplish together, bringing fun, high-quality education and mentorship to more young scientists in the future.
Comments